title: Blockade of CCR5 to protect the liver graft in HIV/HCV co-infected patients.
authors.affiliation: AP-HP, Hôpital Paul Brousse, Département Virologie, Villejuif, France.
authors.forename: Stéphanie
authors.initials: S
authors.lastname: Haïm-Boukobza
authors.forename: Karl
authors.initials: K
authors.lastname: Balabanian
authors.forename: Elina
authors.initials: E
authors.lastname: Teicher
authors.forename: Marion
authors.initials: M
authors.lastname: Bourgeade
authors.forename: Gabriel
authors.initials: G
authors.lastname: Perlemuter
authors.forename: Anne-Marie
authors.initials: AM
authors.lastname: Roque-Afonso
authors.forename: Jean-Charles
authors.initials: JC
authors.lastname: Duclos-Vallee
mesh_terms: D065100:CCR5 Receptor Antagonists; D002634:Chemotaxis, Leukocyte / Q000187:drug effects*; D003510:Cyclohexanes / Q000627:therapeutic use*; D005260:Female; D006086:Graft vs Host Disease / Q000517:prevention & control*; D018380:Hematopoietic Stem Cell Transplantation / Q000009:adverse effects*; D006801:Humans; D008297:Male; D013601:T-Lymphocytes / Q000187:drug effects*; D014230:Triazoles / Q000627:therapeutic use*
chemical_list: D065100:CCR5 Receptor Antagonists; D003510:Cyclohexanes; D014230:Triazoles
keywords: CCR5; Fibrosis; Liver graft rejection; Liver transplantation; Maraviroc